A portfolio-first approach.
EPAGOGE operates a continuous technology development pipeline. Intellectual property is filed before commercial disclosure; applications are engineered and validated before markets are approached. The portfolio is the foundation that commercial strategy is built on.
Work spans three interconnected technical domains.
Cybersecurity & Behavioral Detection
Distributed confidence computation, multi-source behavioral fusion, progressive containment, post-quantum architectural security. Flagship product ATOPOS is the commercial expression of this research.
Semiconductor & Systems
Fabrication methodologies, adaptive tolerance absorption, chiplet architecture, systems-level reliability frameworks. Research connects hardware-level physics to software-level behavioral computation.
Environmental Sensing
Building-integrated substrates for behavioral anomaly detection, integrated sensing and communication architectures, structural health monitoring applications. Early-stage research, not publicly disclosed.
Cross-Domain Mathematics
A common mathematical framework underlies work across all domains. The formal structure is the subject of ongoing publication development and is protected through coordinated patent prosecution.
Twelve-plus patent families filed with the United States Patent and Trademark Office.
The portfolio is structured for defensive depth rather than horizontal breadth. Each patent family builds on the last; prosecution strategy assumes adversarial review and preserves continuation rights for downstream broadening as commercial applications mature.
Specific applications are protected before they are described.
Epagoge does not publish the full theoretical framework underlying the portfolio. Research outputs are disclosed through three channels: issued patents after prosecution is complete, peer-reviewed publications for components suitable for academic release, and restricted technical briefings under non-disclosure agreement for qualified parties.
Commercial evaluators, government program managers, strategic investors, and credentialed technical reviewers may request access to specific portfolio materials through the contact channel. Requests are evaluated for alignment with Epagoge's commercialization priorities and executed under mutual NDA.
General media, speculative partnership proposals, and unsolicited acquisition inquiries receive standard responses without disclosure of portfolio specifics.
Department of Defense SBIR
Phase I technical volume in preparation targeting cybersecurity topics. Supporting documentation includes validation report, budget narrative, and commercialization strategy anchored to the cybersecurity product.
Commercial Pilot Deployment
Thirty-day read-only evaluation being structured with a multi-location retail organization. Metadata-only monitoring, no endpoint installation, zero customer data access.
SAFETY Act Designation
Department of Homeland Security anti-terrorism technology designation application under development. Supporting evidence will include SBIR validation data and commercial pilot performance documentation.
Portfolio Expansion
Provisional filings continue on a rolling basis as research identifies novel inventive subject matter. Non-provisional conversions follow standard twelve-month windows with strategic continuation practice.